2nd Quarter - Report

PARVEN POMPER STRATEGIES, INC. for PFIZER

Firm
Client
Income
$80,000
Expenses
—

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Copyright/Patent/Trademark CPT

Issues relating to compulsory licensing of pharmaceutical patents by foreign countries, and international protection of intellectual property. Issues relating to the merger between Pfizer and Wyeth.

LobbyistCovered position, as disclosed
BRIAN ARTHUR POMPER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

HR 1427, Promoting Innovation and Access to Life-Saving Medicine Act - Issues and provisions relating to follow-on biologics. HR 1548, Pathway for Biosimilars Act - Issues and provisions relating to follow-on biologics. Issues relating to pharmaceuticals and health reform.

LobbyistCovered position, as disclosed
ALIXANDRIA LAPP CoS, Comm. and Pol. Dir., Comm. Dir., Rep. Smith
BRIAN ARTHUR POMPER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1548 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.